These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21543168)

  • 21. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct ELISA kits as a sensitive and selective screening method for abstinence control in urine.
    Kirschbaum KM; Musshoff F; Wilbert A; Röhrich J; Madea B
    Forensic Sci Int; 2011 Apr; 207(1-3):66-9. PubMed ID: 20933345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one-step extraction procedure for the screening of cocaine, amphetamines and cannabinoids in postmortem blood samples.
    Pelição FS; Peres MD; Pissinate JF; De Martinis BS
    J Anal Toxicol; 2014; 38(6):341-8. PubMed ID: 24782143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis.
    Swortwood MJ; Boland DM; DeCaprio AP
    Anal Bioanal Chem; 2013 Feb; 405(4):1383-97. PubMed ID: 23180084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GC-MS determination of amphetamines in serum using on-line trifluoroacetylation.
    Hidvégi E; Fábián P; Hideg Z; Somogyi G
    Forensic Sci Int; 2006 Sep; 161(2-3):119-23. PubMed ID: 16839730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines.
    Kerrigan S; Mellon MB; Banuelos S; Arndt C
    J Anal Toxicol; 2011 Sep; 35(7):444-51. PubMed ID: 21871153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples.
    Kankaanpää A; Gunnar T; Ariniemi K; Lillsunde P; Mykkänen S; Seppälä T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):57-68. PubMed ID: 15358308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Driving under the influence of synthetic phenethylamines: a case series.
    Maas A; Wippich C; Madea B; Hess C
    Int J Legal Med; 2015 Sep; 129(5):997-1003. PubMed ID: 25618172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry.
    Kerrigan S; Banuelos S; Perrella L; Hardy B
    J Anal Toxicol; 2011 Sep; 35(7):459-69. PubMed ID: 21871155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
    Vorce SP; Sklerov JH
    J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine.
    Kraemer T; Maurer HH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):163-87. PubMed ID: 9700558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS).
    Kim EM; Lee JS; Choi SK; Lim MA; Chung HS
    Forensic Sci Int; 2008 Jan; 174(2-3):197-202. PubMed ID: 17553643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of the initial medical examination on matters relating to persons suspected of driving under the influence of amphetamine and its analogs or delta9-tetrahydrocannabinol based on the materials the Department of Forensic Medicine, Pomeranian Medical University in Szczecin].
    Wolski S; Lewandowska E; Kurzejamska-Parafiniuk M
    Ann Acad Med Stetin; 2013; 59(2):147-56. PubMed ID: 25026768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD.
    Kroener L; Musshoff F; Madea B
    J Anal Toxicol; 2003; 27(4):205-12. PubMed ID: 12820742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and simple GC-MS method for determination of psychotropic phenylalkylamine derivatives in nails using micro-pulverized extraction.
    Kim JY; Cheong JC; Lee JI; Son JH; In MK
    J Forensic Sci; 2012 Jan; 57(1):228-33. PubMed ID: 21923795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.